Related references
Note: Only part of the references are listed.Designing Co-Crystals of Pharmaceutically Relevant Compounds That Crystallize with Z′ > 1
Kirsty M. Anderson et al.
CRYSTAL GROWTH & DESIGN (2009)
Dimorphs of a 1:1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph
Srinivasulu Aitipamula et al.
CRYSTENGCOMM (2009)
Co-crystal polymorphs from a solvent-mediated transformation
Joop H. ter Horst et al.
CRYSTAL GROWTH & DESIGN (2008)
Polymorphism in carbamazepine cocrystals
William W. Porter et al.
CRYSTAL GROWTH & DESIGN (2008)
The role of cocrystals in pharmaceutical science
Ning Shan et al.
DRUG DISCOVERY TODAY (2008)
The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics
Annette Bak et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Performance comparison of a co-crystal of carbamazepine with marketed product
Magali B. Hickey et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
N. Blagden et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Sulfa drugs as model cocrystal formers
Mino R. Caira
MOLECULAR PHARMACEUTICS (2007)
A hidden co-crystal of caffeine and adipic acid
Dejan-Kresimir Bucar et al.
CHEMICAL COMMUNICATIONS (2007)
Physical stability enhancement of theophylline via cocrystallization
Andrew V. Trask et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API
Daniel P. McNamara et al.
PHARMACEUTICAL RESEARCH (2006)
What is syncrystallization? States of the pH indicator methyl red in crystals of phthalic acid
JB Benedict et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
The predictably elusive form II of aspirin
P Vishweshwar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Solvent effect on crystal polymorphism: Why addition of methanol or ethanol to aqueous solutions induces the precipitation of the least stable beta form of glycine
I Weissbuch et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Selective polymorph transformation via solvent-drop grinding
AV Trask et al.
CHEMICAL COMMUNICATIONS (2005)
Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients
P Vishweshwar et al.
CHEMICAL COMMUNICATIONS (2005)
Concomitant polymorphs of 2,2 ',6,6 '-tetramethyl-4,4 '-terphenyldiol: the beta-quinol network reproduced in a metastable polymorph
S Aitipamula et al.
CHEMICAL COMMUNICATIONS (2005)
Solvent-drop grinding: green polymorph control of cocrystallisation
AV Trask et al.
CHEMICAL COMMUNICATIONS (2004)
Grouping solvents by statistical analysis of solvent property parameters: implication to polymorph screening
CH Gu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Polymorphism of 1,3,5-trinitrobenzene induced by a trisindane additive
PK Thallapally et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
O Almarsson et al.
CHEMICAL COMMUNICATIONS (2004)
Grinding-induced equimolar complex formation between thiourea and ethenzamide
K Moribe et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2004)
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids
JF Remenar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Toward stereochentical control, monitoring, and understanding of crystal nucleation
I Weissbuch et al.
CRYSTAL GROWTH & DESIGN (2003)
Do polymorphic compounds make good cocrystallizing agents?: A structural case study that demonstrates the importance of synthon flexibility
CB Aakeröy et al.
CRYSTAL GROWTH & DESIGN (2003)
In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats
S Bian et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Engineering crystalline architecture with supramolecular tapes: Studies on secondary donor-acceptor interactions in cocrystals of the cyclic dipeptide of glycine
TJM Luo et al.
CRYSTAL GROWTH & DESIGN (2002)
Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics
N Shan et al.
CHEMICAL COMMUNICATIONS (2002)
Polymorph screening: Influence of solvents on the rate of solvent-mediated polymorphic transformation
CH Gu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate
Y Kobayashi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Share Paper
